ERBB2 and neoplasm: To identify genes involved in tumour cell resistance to T cell killing independent of antigen presentation on MHC, we performed an unbiased whole-genome loss-of-function CRISPR/Cas9 screen in vitro, utilising HER2-directed second-generation mouse CAR-T cells (Fig. 1A).